Immunology from Concept and Experiments to Translation (Immuno ConcEpT) France
Research
Date range: 1 December 2020 - 30 November 2021
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Immunology from Concept and Experiments to Translation (Immuno ConcEpT) published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
3 | 0.38 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 3 | 0.38 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.12 | 0.87 | 0.14 | 0.76 | 0.17 |
Collaboration
Date range: 1 December 2020 - 30 November 2021
International vs. domestic collaboration by Share
- 66.78% Domestic
- 33.22% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Immunology from Concept and Experiments to Translation (Immuno ConcEpT) by Share (10 total)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and University of Bordeaux
(1.10)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and French National Centre for Scientific Research (CNRS)
(0.60)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and Institute for Molecular and Cellular Biology (IBMC)
(0.35)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and Actions for Oncogenesis Understanding and Target Identification in Oncology (ACTION)
(0.35)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and Contrôle des Réponses Immunes B et des Lymphoproliférations (CRIBL)
(0.35)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and ImmuSmol SAS
(0.35)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and National Institute for Health and Medical Research (INSERM)
(0.35)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and University of Strasbourg
(0.33)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and Bergonié Cancer Institute
(0.33)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and University of Limoges (ULIM)
(0.33)
Top 10 international collaborators with Immunology from Concept and Experiments to Translation (Immuno ConcEpT) by Share (9 total)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and New York University (NYU)
(0.70)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and Mount Sinai Health System (MSHS)
(0.59)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and Baylor Scott & White Health
(0.39)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and Scientific Institute for Research, Hospitalization and Healthcare (IRCCS)
(0.17)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and Emory University
(0.11)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and Kyoto University
(0.08)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and Academia Sinica
(0.07)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and Albert Einstein College of Medicine (Einstein)
(0.07)
-
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) and University of Genova
(0.04)
Relationships
Partner Institutions
Immunology from Concept and Experiments to Translation (Immuno ConcEpT) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.